Complex High Risk PCI, commonly referred to as CHIP PCI, is used for selected patients who require coronary revascularisation but face substantially increased procedural or surgical risk.
Patients considered for CHIP PCI may have severe left ventricular dysfunction, complex multivessel coronary disease, unprotected left main disease, heavily calcified arteries, previous failed interventions, or other factors that make conventional treatment particularly challenging.
The first step is determining whether revascularisation is appropriate for the individual patient. This requires assessment of coronary anatomy, symptoms, ischaemia, ventricular function, and the potential benefit of treating the affected vessels.
When PCI is appropriate, complex cases may require advanced techniques, intravascular imaging, calcium modification, and planned haemodynamic support. Depending on the patient's condition and procedure, support technologies can include IABP, Impella, or ECMO.
Intravascular ultrasound can also help the interventional cardiologist assess vessel size, calcium, lesion characteristics, and final stent expansion.
For patients who have been declined for bypass surgery or told that their coronary disease is too complex to treat, a specialist review website can help determine whether a carefully planned complex PCI approach is feasible.
CTOMD provides Complex and High Risk PCI with access to advanced imaging, calcium modification techniques, and haemodynamic support for appropriately selected patients.
Learn more about Complex High Risk PCI at CTOMD: https://ctomd.com/treatments/complex-pci-chip/